Literature DB >> 32396042

Preoperative CT-based Deep Learning Model for Predicting Disease-Free Survival in Patients with Lung Adenocarcinomas.

Hyungjin Kim1, Jin Mo Goo1, Kyung Hee Lee1, Young Tae Kim1, Chang Min Park1.   

Abstract

Background Deep learning models have the potential for lung cancer prognostication, but model output as an independent prognostic factor must be validated with clinical risk factors. Purpose To develop and validate a preoperative CT-based deep learning model for predicting disease-free survival in patients with lung adenocarcinoma. Materials and Methods In this retrospective study, a deep learning model was trained to extract prognostic information from preoperative CT examinations. Data set 1 for training, tuning, and internal validation consisted of patients with T1-4N0M0 adenocarcinoma resected between 2009 and 2015. Data set 2 for external validation included patients with clinical T1-2aN0M0 (stage I) adenocarcinomas resected in 2014. Discrimination was assessed by using Harrell C index and benchmarked against the clinical T category. The Greenwood-Nam-D'Agostino test was used for model calibration. The multivariable-adjusted hazard ratios (HRs) were analyzed with clinical prognostic factors by using the Cox regression. Results Evaluated were 800 patients (median age, 64 years; interquartile range, 56-70 years; 450 women) in data set 1 and 108 patients (median age, 63 years; interquartile range, 57-71 years; 60 women) in data set 2. The C indexes were 0.74-0.80 in the internal validation and 0.71-0.78 in the external validation, both comparable with the clinical T category (0.78 in the internal validation and 0.74 in the external validation; all P > .05). The model exhibited good calibration in all data sets (P > .05). Multivariable Cox regression revealed that model outputs were independent prognostic factors (hazard ratio [HR] of the categorical output, 2.5 [95% confidence interval {CI}: 1.03, 5.9; P = .04] in the internal validation and 3.6 [95% CI: 1.6, 8.5; P = .003] in the external validation). Other than the deep learning model, only smoking status (HR, 3.4; 95% CI: 1.4, 8.5; P = .007) contributed further to prediction of disease-free survival for patients after resection of clinical stage I adenocarcinomas. Conclusion A deep learning model for chest CT predicted disease-free survival for patients undergoing an operation for clinical stage I lung adenocarcinoma. © RSNA, 2020 Online supplemental material is available for this article. See also the editorial by Shaffer in this issue.

Entities:  

Mesh:

Year:  2020        PMID: 32396042     DOI: 10.1148/radiol.2020192764

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  22 in total

1.  Development and validation of a deep learning signature for predicting lymph node metastasis in lung adenocarcinoma: comparison with radiomics signature and clinical-semantic model.

Authors:  Xiaoling Ma; Liming Xia; Jun Chen; Weijia Wan; Wen Zhou
Journal:  Eur Radiol       Date:  2022-09-28       Impact factor: 7.034

Review 2.  A narrative review of deep learning applications in lung cancer research: from screening to prognostication.

Authors:  Jong Hyuk Lee; Eui Jin Hwang; Hyungjin Kim; Chang Min Park
Journal:  Transl Lung Cancer Res       Date:  2022-06

3.  How Many Private Data Are Needed for Deep Learning in Lung Nodule Detection on CT Scans? A Retrospective Multicenter Study.

Authors:  Jeong Woo Son; Ji Young Hong; Yoon Kim; Woo Jin Kim; Dae-Yong Shin; Hyun-Soo Choi; So Hyeon Bak; Kyoung Min Moon
Journal:  Cancers (Basel)       Date:  2022-06-28       Impact factor: 6.575

Review 4.  Role of Artificial Intelligence in Radiogenomics for Cancers in the Era of Precision Medicine.

Authors:  Sanjay Saxena; Biswajit Jena; Neha Gupta; Suchismita Das; Deepaneeta Sarmah; Pallab Bhattacharya; Tanmay Nath; Sudip Paul; Mostafa M Fouda; Manudeep Kalra; Luca Saba; Gyan Pareek; Jasjit S Suri
Journal:  Cancers (Basel)       Date:  2022-06-09       Impact factor: 6.575

5.  Combining Tumor Segmentation Masks with PET/CT Images and Clinical Data in a Deep Learning Framework for Improved Prognostic Prediction in Head and Neck Squamous Cell Carcinoma.

Authors:  Kareem A Wahid; Renjie He; Cem Dede; Abdallah S R Mohamed; Moamen Abobakr Abdelaal; Lisanne V van Dijk; Clifton D Fuller; Mohamed A Naser
Journal:  Head Neck Tumor Segm Chall (2021)       Date:  2022-03-13

6.  Progression Free Survival Prediction for Head and Neck Cancer Using Deep Learning Based on Clinical and PET/CT Imaging Data.

Authors:  Mohamed A Naser; Kareem A Wahid; Abdallah S R Mohamed; Moamen Abobakr Abdelaal; Renjie He; Cem Dede; Lisanne V van Dijk; Clifton D Fuller
Journal:  Head Neck Tumor Segm Chall (2021)       Date:  2022-03-13

Review 7.  Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension.

Authors:  Xiaoxuan Liu; Samantha Cruz Rivera; David Moher; Melanie J Calvert; Alastair K Denniston
Journal:  Lancet Digit Health       Date:  2020-09-09

Review 8.  Artificial Intelligence in Cancer Research and Precision Medicine.

Authors:  Bhavneet Bhinder; Coryandar Gilvary; Neel S Madhukar; Olivier Elemento
Journal:  Cancer Discov       Date:  2021-04       Impact factor: 38.272

9.  Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI Extension.

Authors:  Samantha Cruz Rivera; Xiaoxuan Liu; An-Wen Chan; Alastair K Denniston; Melanie J Calvert
Journal:  BMJ       Date:  2020-09-09

Review 10.  Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension.

Authors:  Samantha Cruz Rivera; Xiaoxuan Liu; An-Wen Chan; Alastair K Denniston; Melanie J Calvert
Journal:  Lancet Digit Health       Date:  2020-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.